Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Early medical abortion using telemedicine – acceptability to patients

View ORCID ProfileChelsey Porter Erlank, View ORCID ProfileJonathan Lord, Kathryn Church
doi: https://doi.org/10.1101/2020.11.11.20229377
Chelsey Porter Erlank
1Evidence to Action Department, MSI Reproductive Choices, London, UK, Postal address: MSI, 1 Conway Street, London, W1T 6LP, Email:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chelsey Porter Erlank
  • For correspondence: chelsey.porter@MSIChoices.org
Jonathan Lord
2Medical Director, MSI Reproductive Choices, London, UK, Email:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan Lord
  • For correspondence: jonathan.lord@msichoices.org.uk jonathan.lord@MSIChoices.org.uk
Kathryn Church
3Evidence to Action Department, MSI Reproductive Choices, London, UK, Email:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kathryn.church@MSIChoices.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Introduction The English government approved both stages of early medical abortion (EMA) for at-home use on 30th March 2020. MSI Reproductive Choices UK (MSUK), one of the largest service providers of abortion services in England, launched a telemedicine EMA pathway on 6th April 2020.

Methods A sample of all MSUK’s telemedicine EMA patients between April and August 2020 were invited to opt in to a follow-up call to answer clinical and satisfaction questions. 1,243 (13.7% of all telemedicine EMAs) were successfully followed-up, on average within five days post-procedure. Responses were analysed quantitatively and descriptively. The sample was compared to the total telemedicine EMA population on nine sets of background characteristics to check sample validity, and all results were tested across the same nine characteristics for variation.

Results Patients reported high confidence in telemedicine EMA and high satisfaction with the convenience, privacy and ease of managing their abortion at home. No patient reported that they were unable to consult privately. Over 80% of patients reported preferring the telemedicine pathway, and two-thirds that they would choose telemedicine again if COVID-19 were no longer an issue.

Discussion Telemedicine EMA is a valued, private, convenient and easier option that is highly acceptable for patients seeking an abortion, especially those for whom in-clinic visits are logistically or emotionally challenging. Evidence that this pathway would be a first choice again in future for most patients supports the case to make access to telemedicine EMA permanent.

Key message points

  • On 30th March 2020, the English government approved both stages of early medical abortion (EMA) for at-home use, paving the way for telemedicine EMA provision.

  • MSUK patients receiving routine follow-up calls reported high confidence in telemedicine EMA and high satisfaction with the privacy, convenience and ease of this pathway.

  • Two-thirds of telemedicine EMA patients reported they would choose this pathway again in future, demonstrating that it should remain available after the COVID-19 pandemic.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-abortion/

Funding Statement

N/A

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The MSI Reproductive Choices UK Board reviewed the study protocol and declared the use of pre-collected, fully de-identified data exempt from the need for approval. Approval was also gained from the institution's information governance lead.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Updated organisational and contact details (institution name has changed); correction to clarify where UK arm of Charity had responsibility as opposed to international. To note paper has now been peer-reviewed and accepted for publication subject to amendments; we will upload the final version when it is accepted

Data Availability

Confirmed that data is available on MSUK secure server

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 19, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Early medical abortion using telemedicine – acceptability to patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Early medical abortion using telemedicine – acceptability to patients
Chelsey Porter Erlank, Jonathan Lord, Kathryn Church
medRxiv 2020.11.11.20229377; doi: https://doi.org/10.1101/2020.11.11.20229377
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Early medical abortion using telemedicine – acceptability to patients
Chelsey Porter Erlank, Jonathan Lord, Kathryn Church
medRxiv 2020.11.11.20229377; doi: https://doi.org/10.1101/2020.11.11.20229377

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Sexual and Reproductive Health
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (577)
  • Anesthesia (139)
  • Cardiovascular Medicine (1942)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (331)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (697)
  • Epidemiology (11089)
  • Forensic Medicine (8)
  • Gastroenterology (620)
  • Genetic and Genomic Medicine (3159)
  • Geriatric Medicine (307)
  • Health Economics (561)
  • Health Informatics (2040)
  • Health Policy (862)
  • Health Systems and Quality Improvement (782)
  • Hematology (309)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12702)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2979)
  • Nursing (163)
  • Nutrition (462)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1548)
  • Ophthalmology (475)
  • Orthopedics (185)
  • Otolaryngology (265)
  • Pain Medicine (201)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (910)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (354)
  • Psychiatry and Clinical Psychology (2777)
  • Public and Global Health (5584)
  • Radiology and Imaging (1090)
  • Rehabilitation Medicine and Physical Therapy (631)
  • Respiratory Medicine (757)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (287)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (131)